MarketInOut Stock Screener Log In | Sign Up
 

Ligand Pharmaceuticals Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 07/15/2026 16:00
Ligand Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization6,031.76 mln
Float19.53 mln
Earnings Date08/11/2026

EPS

7.46
Stretched

P / E

39.71
Overvalued

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-3.59
Highly reliable

1-Year Forecast

298
Fairly priced

Relative Strength

21 / 100
Significantly lagging

Business Description

Ligand Pharmaceuticals is a Florida-based biopharmaceutical company founded in 1987 that builds revenue by licensing a broad portfolio of drug assets to partners around the world rather than selling medicines directly to patients. Its portfolio spans a wide range of medical needs, including cancer, infectious disease, bone health, diabetes, and rare conditions, with partner products already approved and generating royalties alongside a pipeline of drugs still in development. This business model allows Ligand to earn income from multiple revenue streams while sharing the costs and risks of bringing new treatments to market.

Key Fundamentals

EPS7.46
P/E39.71
ROE16.73
RPS13.48
ROIC11.69
ROA11.95
Interest Cover18.09
EBITDA, mln224
EV / EBITDA25.68
EV / EBIT30.16
Revenue, mln274
EV / Revenue20.93

Financial Strength

Altman Z-Score8.61
Piotroski F-Score 6 / 9
Beneish M-Score-3.59
Price to Intrinsic Value4.23
Price to Graham Number3.77
1-Year Target Price298
Shiller PE Ratio54.25
Short Ratio4.25
Short % of Float12.68

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -5.91% 13 / 100   
1 Month 15.93% 91 / 100   
2 Months 44.45% 92 / 100   
6 Months 43.25% 92 / 100   
1 Year 133% 95 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us